Unified Parkinson’s Disease Rating Scale

Abstract

The Unified Parkinson’s Disease Rating Scale (UPDRS) is a fundamental clinical assessment tool utilized to systematically quantify both the motoric and behavioral aspects of Parkinson’s disease (PD). Developed to provide a comprehensive, singular numerical score reflecting the patient’s current status, the scale typically asks for symptom evaluation over the preceding week. The instrument comprises 42 items distributed across four distinct subcategories, covering domains from mental function to complications arising from therapeutic interventions. The UPDRS has historically served as a critical endpoint measure in clinical trials assessing the efficacy of new treatments for PD.

Keywords

Unified Parkinson’s Disease Rating Scale, UPDRS, Parkinson’s disease, Motor Function, Behavioral Assessment, Activities of Daily Living, Neurological Scale, Fahn & Elton, Clinical Assessment.

Authors

Fahn S, Elton RL (1987); Dutch Version: van Weegen EEH, et al. (2005)

Purpose

The primary purpose of the UPDRS is to provide a standardized, quantifiable measure for evaluating the severity and progression of Parkinson’s disease (PD) across its various manifestations. This scale is indispensable for clinicians monitoring individual patient status over time and for researchers conducting clinical trials where consistent measurement of symptom change is required to determine the success of pharmacological or surgical interventions.

The scale’s structure allows for detailed tracking of specific symptom clusters, enabling healthcare providers to tailor management strategies. By converting complex clinical observations into a robust numerical score, the UPDRS facilitates objective comparison between different patient populations and treatment groups.

Construct

The UPDRS measures the complex, multi-dimensional construct of Parkinson’s disease severity and disability. This construct is broken down into four major areas, reflecting the comprehensive nature of PD pathology:

• Part I: Assessment of Mentation, Behavior, and Mood (Non-Motor Symptoms).
• Part II: Assessment of Activities of Daily Living (ADL), focusing on self-reported disability.
• Part III: Objective Motor Examination, assessed by a trained clinician.
• Part IV: Assessment of Complications of Therapy, primarily focusing on dyskinesias and fluctuations related to dopaminergic therapy.

The total score is a summation of these parts, where higher scores indicate greater impairment and disease severity. The inclusion of both self-reported (Part II) and objective observer-rated items (Part III) ensures a holistic view of the disease burden.

Validity

The original UPDRS demonstrated strong foundational validity, establishing its relevance as a clinical measure. Content validity is supported by the comprehensive coverage of the primary symptoms of PD, including tremor, rigidity, bradykinesia, and gait abnormalities, as well as crucial non-motor features.

Numerous studies have confirmed the concurrent validity of the UPDRS, showing high correlations between UPDRS scores and other established measures of PD impairment, such as the Hoehn and Yahr Scale and the Schwab and England Activities of Daily Living Scale. Construct validity is evidenced by the scale’s ability to distinguish between different stages of PD progression and its sensitivity to change following effective treatment administration.

Reliability

The reliability of the UPDRS has been extensively studied, particularly regarding inter-rater reliability and test-retest reliability. Part III (the Motor Examination) typically exhibits high inter-rater reliability when clinicians are adequately trained and standardized procedures are followed, which is critical for its use in multi-center clinical trials.

However, reliability for Parts I and II (which rely on patient or caregiver report) can be more variable. The motor items are generally considered robust, demonstrating acceptable test-retest consistency over short periods, provided that the patient’s clinical state (especially the ‘ON’ or ‘OFF’ medication state) remains consistent.

Factor Analysis

Early factor analytic studies of the UPDRS generally supported the four-part structure proposed by Fahn and Elton. However, deeper analyses, particularly utilizing Part III (Motor Examination), often revealed multiple underlying factors within the motor domain, such as axial impairment, tremor, and limb bradykinesia.

These analyses confirmed that while the UPDRS provided a valuable total score, the motor dimension was complex and multifaceted. The results from various factor analyses ultimately contributed to the development and refinement of the Movement Disorder Society-sponsored Revision of the UPDRS (MDS-UPDRS), which features a more rigorous psychometric foundation and reorganized domain structure.

Instrument

Test Type: Questionnaire and Clinical Observation Scale

Format: 42 items divided into four sections (I: Mentation, Behavior, Mood; II: ADL; III: Motor Examination; IV: Complications of Therapy).

Language Available: Original English, Dutch Version (van Weegen EEH, et al., 2005), and numerous other translations.

Population Group: Patients diagnosed with Parkinson’s disease.

Age Group: Adults, Elderly

Population Details: Suitable for assessing individuals across the spectrum of PD severity.

Test Methodology: The scale utilizes a mixed methodology. Part I and II rely on interview and self-report (or caregiver report) covering the preceding week. Part III is an objective physical examination performed by a trained rater. Scoring predominantly uses a 5-point scale (0-4, where 0=Normal and 4=Severe impairment). Items 35, 36, 37, 38, 40, 41, and 42 use a 3-point scale (0-2).

Keywords

Neurology, Movement Disorder, Clinical Trial Outcome, Bradykinesia, Tremor, Rigidity, Activities of Daily Living (ADL), Rating Scale, Disability Assessment.

Authors

Author ORCID Identifier: Not specified in source.

Affiliation Email addresses: Not specified in source.

Correspondence Address: Not specified in source.

Permissions & Fee and Test Year

The UPDRS was first published in 1987 by Fahn and Elton. The instrument is generally considered to be in the public domain for non-commercial clinical and research use, though specific versions or translations may require permission from the respective copyright holders.

The original PDF for the explanation form (Toelichtingsformulier) can be downloaded here: Toelichtingsformulier PDF.

The original PDF for the measurement instrument (Meetinstrument) can be downloaded here: Meetinstrument PDF.

Reference’s

The primary reference for the scale is the original publication by its authors. The Dutch version provides an additional reference for validation and translation efforts.

• Fahn S, Elton RL. Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, editors. Recent Developments in Parkinson’s Disease. Vol 2. Florham Park, NJ: Macmillan Health Care Information; 1987. p. 153–163.
• van Weegen EEH, et al. (2005). Validation of the Dutch version of the UPDRS.

Items of the Unified Parkinson’s Disease Rating Scale

IMPORTANT: The following scale items must be preserved in their original language and must not be changed in any way.

The UPDRS consists of 42 items distributed across four subcategories:

1. I: Mentation, Behavior, and Mood (Items 1-4): Assesses intellectual impairment, thought disorder, depression, and motivation/initiative.

2. II: Activities of Daily Living (ADL) (Items 5-18): Assesses self-reported difficulties in speech, swallowing, handwriting, dressing, hygiene, falling, freezing, walking, and tremor while performing ADL.

3. III: Motor Examination (Items 19-34): A clinical assessment of speech, facial expression, tremor (rest, action, postural), rigidity, finger taps, rapid alternating movements, leg agility, gait, posture, and body bradykinesia/hypokinesia. This section is observer-rated.

4. IV: Complications of Therapy (Items 35-42): Evaluates the presence and severity of dyskinesias (duration, disability, pain) and clinical fluctuations (e.g., ‘ON-OFF’ periods, ‘wearing OFF’).

Scoring for most items (1-34, 39) utilizes a 5-point scale (0=Normal to 4=Severe impairment). Items 35, 36, 37, 38, 40, 41, and 42 use a 3-point scale (0-2).